Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.89%
SPX
+1.52%
IXIC
+1.88%
FTSE
+0.13%
N225
+0.05%
AXJO
-0.57%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

About

What does GILD do?
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
Sector
💻 Health Care
IPO
CEO
Employees
17,600
Headquarters
California, USA
Website
http://www.gilead.com

Key Stats

Market Cap
142.77B
Dividend Yield
0.00%
P/E Ratio
22.62
EPS
0.37
Revenue
28.75B
Avg. Volume
5.63M

Recently from Cashu

publisher logo
Cashu

Gilead Sciences and Walgreens: Innovating Healthcare Through Strategic Partnerships and Digital Expansion

3 days ago
publisher logo
Cashu

Gilead Sciences Sees Short Interest Drop Amid Rising Market Optimism and Potential Growth

8 days ago
publisher logo
Cashu

Gilead Sciences Sees Decrease in Short Interest, Indicating Positive Market Sentiment

10 days ago
Stocks
Health Care
gild
Gilead Sciences
NASDAQ: GILD
-1.37 (-1.18%)
114.77
USD
At close at Aug 22, 20:35 UTC
Summary
News
Signals
Benchmarks
Financials